Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Long-term safety and outcomes of repeated rituximab in adults with schizophrenia spectrum disorder

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden
  • Long‑Term Safety and Tolerability of KarXT in Adolescents with Schizophrenia and of KarXT + KarX‑EC in Children and Adolescents with Autism‑Related Irritability

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Romania
  • Study on Cannabidiol as an Add-On Treatment for Patients with Early Schizophrenia

    Not yet recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study on Improving Social Skills in Schizophrenia Using Oxytocin or Placebo as an Add-On Treatment for Patients with Schizophrenia Spectrum Disorders

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study on Enhanced Treatment for Schizophrenia, Depression, and Bipolar Disorder Using Esketamine, Bupropion, and Quetiapine for Patients with Initial Treatment Failure

    Not yet recruiting

    3 1 1 1
    Austria Germany Italy Spain
  • Study on the Effectiveness and Safety of Cariprazine for Adolescents (13-17 years) with Schizophrenia

    Not recruiting

    3 1 1
    Investigated Diseases:
    Bulgaria Romania
  • Long-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) in patients with inadequately controlled schizophrenia symptoms

    Not recruiting

    3 1 1
    Investigated Diseases:
    Bulgaria
  • Study on Rituximab for Adults with Schizophrenia Spectrum Disorder

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden
  • Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Croatia Czechia Romania Slovakia Spain
  • Study on Tolcapone for Improving Cognitive Symptoms in Patients with Long-Standing Schizophrenia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain